These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24514004)

  • 21. Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants.
    Kim S; Lalani S; Parekh VV; Wu L; Van Kaer L
    Expert Rev Vaccines; 2008 Dec; 7(10):1519-32. PubMed ID: 19053208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-7 During Antigenic Stimulation Using Allogeneic Dendritic Cells Promotes Expansion of CD45RA
    Trujillo-Ocampo A; Cho HW; Clowers M; Pareek S; Ruiz-Vazquez W; Lee SE; Im JS
    Front Immunol; 2020; 11():567406. PubMed ID: 33329531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invariant NKT cells: regulation and function during viral infection.
    Juno JA; Keynan Y; Fowke KR
    PLoS Pathog; 2012; 8(8):e1002838. PubMed ID: 22916008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses.
    Stolk DA; de Haas A; Vree J; Duinkerken S; Lübbers J; van de Ven R; Ambrosini M; Kalay H; Bruijns S; van der Vliet HJ; de Gruijl TD; van Kooyk Y
    Front Immunol; 2020; 11():990. PubMed ID: 32536918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophils license iNKT cells to regulate self-reactive mouse B cell responses.
    Hägglöf T; Sedimbi SK; Yates JL; Parsa R; Salas BH; Harris RA; Leadbetter EA; Karlsson MC
    Nat Immunol; 2016 Dec; 17(12):1407-1414. PubMed ID: 27798616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy.
    Taniguchi M; Tashiro T; Dashtsoodol N; Hongo N; Watarai H
    Int Immunol; 2010 Jan; 22(1):1-6. PubMed ID: 19858073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes.
    Gehrmann U; Hiltbrunner S; Georgoudaki AM; Karlsson MC; Näslund TI; Gabrielsson S
    Cancer Res; 2013 Jul; 73(13):3865-76. PubMed ID: 23658368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NKT Cell-Driven Enhancement of Antitumor Immunity Induced by Clec9a-Targeted Tailorable Nanoemulsion.
    Lam PY; Kobayashi T; Soon M; Zeng B; Dolcetti R; Leggatt G; Thomas R; Mattarollo SR
    Cancer Immunol Res; 2019 Jun; 7(6):952-962. PubMed ID: 31053598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serpinb1a Is Dispensable for the Development and Cytokine Response of Invariant Natural Killer T Cell Subsets.
    Leborgne NGF; Taddeo A; Freigang S; Benarafa C
    Front Immunol; 2020; 11():562587. PubMed ID: 33262755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner.
    King IL; Fortier A; Tighe M; Dibble J; Watts GF; Veerapen N; Haberman AM; Besra GS; Mohrs M; Brenner MB; Leadbetter EA
    Nat Immunol; 2011 Nov; 13(1):44-50. PubMed ID: 22120118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Harnessing Invariant NKT Cells to Improve Influenza Vaccines: A Pig Perspective.
    Yang G; Richt JA; Driver JP
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29280974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Influence of Invariant Natural Killer T Cells on Humoral Immunity to T-Dependent and -Independent Antigens.
    Lang ML
    Front Immunol; 2018; 9():305. PubMed ID: 29520280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant effects of invariant NKT cell ligand potentiates the innate and adaptive immunity to an inactivated H1N1 swine influenza virus vaccine in pigs.
    Dwivedi V; Manickam C; Dhakal S; Binjawadagi B; Ouyang K; Hiremath J; Khatri M; Hague JG; Lee CW; Renukaradhya GJ
    Vet Microbiol; 2016 Apr; 186():157-63. PubMed ID: 27016770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate and adaptive stimulation of murine diverse NKT cells result in distinct cellular responses.
    Tripathi P; Sedimbi SK; Singh AK; Löfbom L; Issazadeh-Navikas S; Weiss S; Förster I; Karlsson MCI; Yrlid U; Kadri N; Cardell SL
    Eur J Immunol; 2019 Mar; 49(3):443-453. PubMed ID: 30427069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycolipid activators of invariant NKT cells as vaccine adjuvants.
    Kharkwal SS; Arora P; Porcelli SA
    Immunogenetics; 2016 Aug; 68(8):597-610. PubMed ID: 27377623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination with antigen-transfected, NKT cell ligand-loaded, human cells elicits robust in situ immune responses by dendritic cells.
    Shimizu K; Mizuno T; Shinga J; Asakura M; Kakimi K; Ishii Y; Masuda K; Maeda T; Sugahara H; Sato Y; Matsushita H; Nishida K; Hanada K; Dorrie J; Schaft N; Bickham K; Koike H; Ando T; Nagai R; Fujii S
    Cancer Res; 2013 Jan; 73(1):62-73. PubMed ID: 23108144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memory Follicular Helper Invariant NKT Cells Recognize Lipid Antigens on Memory B Cells and Elicit Antibody Recall Responses.
    Chen Z; Zhu S; Wang L; Xie D; Zhang H; Li X; Zheng X; Du Z; Li J; Bai L
    J Immunol; 2018 May; 200(9):3117-3127. PubMed ID: 29581354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand.
    Petersen TR; Sika-Paotonu D; Knight DA; Dickgreber N; Farrand KJ; Ronchese F; Hermans IF
    Immunol Cell Biol; 2010 Jul; 88(5):596-604. PubMed ID: 20142835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion.
    Paquin-Proulx D; Gibbs A; Bächle SM; Checa A; Introini A; Leeansyah E; Wheelock CE; Nixon DF; Broliden K; Tjernlund A; Moll M; Sandberg JK
    J Immunol; 2016 Sep; 197(5):1843-51. PubMed ID: 27481843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.
    Macho-Fernandez E; Cruz LJ; Ghinnagow R; Fontaine J; Bialecki E; Frisch B; Trottein F; Faveeuw C
    J Immunol; 2014 Jul; 193(2):961-9. PubMed ID: 24913977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.